A panel of DNA methylation markers for the detection of prostate cancer from FV and DRE urine DNA.

about

A panel of DNA methylation markers for the detection of prostate cancer from FV and DRE urine DNA.

Item

http://www.wikidata.org/entity/Q55517990

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh

2018年學術文章

@zh-hant

name

A panel of DNA methylation mar ...... cer from FV and DRE urine DNA.

@en

A panel of DNA methylation mar ...... cer from FV and DRE urine DNA.

@nl

type

Item

label

A panel of DNA methylation mar ...... cer from FV and DRE urine DNA.

@en

A panel of DNA methylation mar ...... cer from FV and DRE urine DNA.

@nl

altLabel

A panel of DNA methylation mar ...... ncer from FV and DRE urine DNA

@en

prefLabel

A panel of DNA methylation mar ...... cer from FV and DRE urine DNA.

@en

A panel of DNA methylation mar ...... cer from FV and DRE urine DNA.

@nl

P1476

A panel of DNA methylation mar ...... cer from FV and DRE urine DNA.

@en

P2093

Andrew Decatus

http://www.w3.org/2001/XMLSchema#string

Deborah Nusskern

http://www.w3.org/2001/XMLSchema#string

Eric Harvey

http://www.w3.org/2001/XMLSchema#string

Igor Brikun

http://www.w3.org/2001/XMLSchema#string

Lin Li

http://www.w3.org/2001/XMLSchema#string

P2860

Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis

Overdiagnosis and overtreatment of prostate cancer

10-Year Outcomes after Monitoring, Surgery, or Radiotherapy for Localized Prostate Cancer

Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence

Validation study of genes with hypermethylated promoter regions associated with prostate cancer recurrence.

Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up.

Measurement of GSTP1 promoter methylation in body fluids may complement PSA screening: a meta-analysis

High-risk prostate cancer-classification and therapy.

Validation of an RNA cell cycle progression score for predicting death from prostate cancer in a conservatively managed needle biopsy cohort

Epigenomic profiling of DNA methylation in paired prostate cancer versus adjacent benign tissue

P2888

s13148-018-0524-x

P304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S13148-018-0524-X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Diha Freije

P577

2018-07-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1105290470

http://www.w3.org/2001/XMLSchema#string

P698

29988684

http://www.w3.org/2001/XMLSchema#string

P921

molecular biology

P932

6029393

http://www.w3.org/2001/XMLSchema#string